Amphastar Pharmaceuticals, Inc. (AMPH) revenue

Revenue · fiscal 2025
$719.89M

Amphastar Pharmaceuticals, Inc. (AMPH) reported revenue of $719.89M in fiscal 2025 (the year ended December 31, 2025). That is 1.7% lower than the $731.97M of fiscal 2024. Figures as of 18 Nov 2026, 12:56 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$719.89M
Change on fiscal 2024
−1.7%
Growth, 5 years
+15.5% a year
Growth, 10 years
+11.1% a year
Highest on record
$731.97Mfiscal 2024
Lowest on record
$204.32Mfiscal 2012
Fiscal years on record
142012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amphastar Pharmaceuticals, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 15.5% a year; over ten years the rate was 11.1% a year. Across the 14 fiscal years on record (2012–2025), the highest was $731.97M in fiscal 2024 and the lowest $204.32M in fiscal 2012.

History · 14 fiscal years

Revenue by fiscal year

Amphastar Pharmaceuticals, Inc. revenue, year by year

Amphastar Pharmaceuticals, Inc. (AMPH) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$719.89M 1.7% down
2024$731.97M 13.6% up
2023$644.40M 29.1% up
2022$498.99M 14.0% up
2021$437.77M 25.1% up
2020$349.85M 8.5% up
2019$322.36M 9.4% up
2018$294.67M 22.7% up
2017$240.18M 5.9% down
2016$255.17M 1.4% up
2015$251.52M 19.5% up
2014$210.46M 8.4% down
2013$229.68M 12.4% up
2012$204.32M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on AMPH

Amphastar Pharmaceuticals, Inc., figure by figure

Amphastar Pharmaceuticals, Inc. (AMPH) overview: price, valuation and scorecard

Amphastar Pharmaceuticals, Inc. revenue: questions and answers

What is Amphastar Pharmaceuticals, Inc.'s revenue?

Amphastar Pharmaceuticals, Inc. (AMPH) reported revenue of $719.89M in fiscal 2025 (the year ended December 31, 2025). That is 1.7% lower than the $731.97M of fiscal 2024.

What is the growth rate of Amphastar Pharmaceuticals, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 15.5% a year; over ten years the rate was 11.1% a year.

What are the highest and lowest revenue figures on record for Amphastar Pharmaceuticals, Inc.?

Across the 14 fiscal years on record (2012–2025), the highest was $731.97M in fiscal 2024 and the lowest $204.32M in fiscal 2012.

How is Amphastar Pharmaceuticals, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Amphastar Pharmaceuticals, Inc. it is on record here for 14 fiscal years, 2012 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amphastar Pharmaceuticals, Inc. (AMPH) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/AMPH/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.